Phase Ib study of PTC299, a novel oral inhibitor of tumor VEGF expression, in patients with advanced cancer Meeting Abstract
| Authors: | Schwartz, G. K.; Dickson, M. A.; Callahan, L. A.; Darby, C. H.; Llorente, M.; Cao, Y.; Dials, H. J.; Miller, L. L.; Miao, H. H. |
| Abstract Title: | Phase Ib study of PTC299, a novel oral inhibitor of tumor VEGF expression, in patients with advanced cancer |
| Meeting Title: | 46th Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 28 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2010 Jun 4-8 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2010-05-20 |
| Start Page: | 243s |
| Language: | English |
| ACCESSION: | WOS:000208852003246 |
| DOI: | 10.1200/jco.2010.28.15_suppl.3041 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 3041 -- S -- Source: Wos |
Altmetric
Citation Impact
BMJ Impact Analytics
